Monte Rosa Therapeutics GLUE SEC Filings

NASDAQ GLUE
$13.84 -0.54 (-3.76%)
As of: Sep 4, 2026 · 3:59 PM EDT
EDGAR Disclosures

Regulatory Filings

Source SEC EDGAR

Every regulatory document Monte Rosa Therapeutics, Inc. (GLUE) has filed with the SEC, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

# Form Type Form Group Accession Date Filing Index